Neural, Cognitive, and Biomechanical Determinants of Falls in Older Adults

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorUniversity of Sharjah

About this trial

The goal of this clinical trial with an embedded observational phase is to evaluate whether a phenotype-guided, personalized rehabilitation program can improve fall risk and underlying neural control mechanisms in older adults aged ≥65 years, including both high and low fall-risk individuals.

The main questions it aims to answer are:

Do older adults at high fall risk exhibit altered neural, neurocognitive, and biomechanical profiles compared with low/no fall-risk individuals? Does personalized rehabilitation guided by neurophysiological and neurocognitive profiles result in greater reductions in fall risk and improvements in motor control compared with conventional rehabilitation?

Researchers will compare personalized phenotype-guided rehabilitation to conventional evidence-based fall-prevention exercise to determine whether targeted, mechanism-based intervention leads to superior clinical and mechanistic outcomes.

Participants will:

Undergo a comprehensive multimodal assessment including neurophysiological (EEG, EMG), neurocognitive (fNIRS, dual-task testing), and biomechanical (gait and balance) measures Be classified into fall-risk and neurophysiological control profiles based on assessment results (Phase 2 - high fall-risk participants only) be randomly assigned to either personalized rehabilitation or conventional rehabilitation Attend supervised exercise sessions 2-3 times per week for 8-12 weeks Complete gait, balance, and cognitive-motor assessments before and after the intervention Record falls prospectively using monthly fall diaries and follow-up monitoring over 3-6 months

Eligibility criteria

Qualifiers

Age ≥ 65 years

Community-dwelling

Ability to ambulate independently (with or without assistive device)

Ability to understand instructions and provide informed consent

Disqualifiers

Neurological conditions affecting gait or balance (e.g., stroke, Parkinson's disease)

Severe musculoskeletal disorders limiting mobility

Severe cognitive impairment (e.g., inability to follow instructions or MoCA < 18)

Uncontrolled cardiovascular or metabolic conditions

Trial design

Treatments tested in this trial

  • Personalized Neurophysiological Rehabilitation
  • Conventional Fall-Prevention Exercise Program

Treatment groups

80 Participants
are divided into 4 treatment groups

Sponsors and collaborators